Last updated on September 2005

Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Acute | Liver Failure
  • Age: Between 16 - 100 Years
  • Gender: Male or Female
  • Other:
    Clinical diagnosis of fulminant or late-onset hepatic failure
    Must be unable to receive liver transplantation

You may not be eligible for this study if the following are true:

  • Under 16 years old
    Cancer patients
    Pregnancy-aged women
    Impaired renal function
    Impaired cardiac function
    Severe complications including pneumonia, sepsis, DIC and so on

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.